Clinical Trial Update: Dexmedetomidine Supplemented Analgesia and Delirium After Hip Fracture Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dexmedetomidine-supplemented analgesia to reduce postoperative delirium after hip fracture surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture
• Postoperative Delirium

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Peking University First Hospital | Conditions: Elderly, Hip Fracture Surgery | Phase 4 | Status: TERMINATED